Aspects of the present invention include methods and compositions related to the production identification and use of embryonic progenitor cell lines that are capable of undergoing chondrogenesis. A number of exemplary chondrogenic cell lines derived from primordial stem cells are disclosed. The chondrogenic cell lines described herein are robust can expand for >40 passages and have site-specific purity thus providing for compositions and methods of producing diverse cartilage types with unique molecular compositions for use in research and therapy.
